Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?
about
Antagonism of alpha2A-adrenoceptor: a novel approach to inhibit inflammatory responses in sepsisDrotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysisDesign, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock.Patience and change: a conflict of interests?Drotrecogin alfa (activated) in the treatment of severe sepsis.Activated protein C in sepsis: the promise of nonanticoagulant activated protein C.Effect of sepsis therapies on health-related quality of life.Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of deathActivated protein C in sepsis: down but not out, yet.Is There NO Treatment For Severe Sepsis?Drotrecogin alfa (activated): down and not out, but not really in either.Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death.
P2860
Q28583909-033C3105-6A31-46A9-B2A9-A8924A153B71Q33288889-C661E919-6FFD-4998-915C-5F4BEF21BD54Q34370297-D008BE11-309B-4B1A-853E-11F5D427DBFEQ35544754-A7D11175-C963-4215-A2E0-9BAC7BAF4010Q36607385-D87798D7-CBE1-411E-AAC7-1C6AC2ECB7C4Q37241529-34044E46-8A88-46B4-8895-3FA44B84A7F6Q38275323-1554B46D-8B63-4385-98AF-0D1491187461Q42034746-00AAD719-502B-4EE3-B2BF-B7CDBE1B845FQ42081039-C77681E9-4909-4387-9F35-73E5E5188C70Q42714463-5FC0AE30-49F4-430D-8ED6-82FACB2E6A39Q42745409-CA8D9C42-396D-4FFE-8C38-548CDAECF893Q42962064-82569B5A-2E52-49E5-AD15-140B1DDEA771
P2860
Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis?
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@ast
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@en
type
label
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@ast
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@en
prefLabel
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@ast
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@en
P2093
P2860
P921
P356
P1433
P1476
Drotrecogin alfa (activated): ...... y patients with severe sepsis?
@en
P2093
Jan O Friedrich
Maureen O Meade
Neill K J Adhikari
P2860
P2888
P356
10.1186/CC4947
P577
2006-06-02T00:00:00Z
P5875
P6179
1037676871